5.12.2022
Overall, the study findings showed that breakthrough SARS-CoV-2 infection elicited longer-lasting protection against subsequent infections compared to booster vaccinations, despite the fact that both booster vaccinations and breakthrough infections result in a significant increment in anti-spike IgG antibody levels, irrespective of the booster vaccine type and the primary vaccine course.
ECIPA Healthcare 